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Abstract 
Background: For patients with Obstetrical Brachial Plexus Injury (OBPI) that do not obtain a 
functional recovery, treatment is primarily surgical in nature. Surgical treatment involves 
removal of scar tissue, neurolysis, and then bridging the nerve discontinuity or block with a 
nerve graft. Standardly, nerve graft was autograft using sural nerve.  More recently, a 
decellularized processed cadaveric nerve allograft (Axogen) has been utilized in numerous 
peripheral nerve injury repairs but has not been used in pediatric OBPI. Both types of nerve 
graft potentially provide a three-dimensional extracellular matrix that promotes Schwann cell 
migration and axon regeneration.  
Object: To determine the functional efficacy of acellular processed nerve allografts (Axogen) as 
compared to sural nerve autografts taken at time of surgery. 
Methods: This is a retrospective case cohort of patients who underwent surgical repair of an 
OBPI at Barrow Neurological Institute at Phoenix Children’s Hospital using either a sural nerve 
autograft or a decellularized processed cadaveric nerve allograft (Axogen). There were 50 
patients total, 22 in the autograft (control) and 30 in the allograft (intervention) groups. The 
primary outcome measures were motor strength and functionality measured by the British 
motor strength score and Mallet score, respectively. Secondary outcomes included surgical 
time, rate of complications, and future surgeries. Means and standard deviations (SD) of our 
outcomes were analyzed and are reported pre- and post-surgery.   
Results: There was no significant difference in the motor strength and functional outcomes 
between the sural nerve autografts and allografts in follow-up to the surgery. Mean follow up 
was 614 days (SD = 547). The BRMC Motor Strength Score was statistically significant for each 
muscle group we measured except for elbow extension and each component of the Mallet 
Score showed statistically significant increases. Allografts had shorter operative time (Beta (95% 
CI): -30.7 minutes (-62.7, 1.31)) but the same rate of future surgeries although this association 
only trended toward significance with a p = 0.06. Two patients had superficial infections with 
stitch abscesses in the autograft group at the sural nerve harvest site and no infections in the 
 
 
allograft group (9% vs. 0%) (p=0.17). All patients with the autograft had anesthesia in the sural 
nerve distribution on the dorsum of the foot. 
Conclusions: These data would suggest that nerve allografts can be utilized in OBPI repair as 
they have comparable outcomes to autograft but are less invasive, requiring only one surgical 
site, decreased surgical time, and decreased risk of complications.  
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Introduction 
Brachial Plexus Injury 
The brachial plexus refers to the nerve roots from C5 to T1 and provides the motor and sensory 
innervation for the upper extremity. Injury to the brachial plexus disrupts this innervation and 
can result in a number of different pathologies based on the extent of injury. Sunderland 
classifies peripheral nerve injuries into five classes from least to most severe. First degree 
(neurapraxia) is demyelination of the nerve. Second degree (axonotmesis) involves Wallerian 
degeneration of the distal portion of the nerve and proximal nerve degeneration. Third degree 
is similar to second degree but also involves damage to the endoneurial tubes. Fourth degree 
also includes an area of scar that prevents axon regeneration, called a neuroma. Fifth degree 
(neurotmesis) is complete transection of a nerve. Avulsion is a type of fifth degree injury where 
the nerve root is separated from the spinal cord. Injury to all of the nerves of the brachial 
plexus results in a flail upper limb with no motor or sensory function. More commonly, an 
upper plexus injury (C5, C6, and sometimes C7) occurs and is referred to as Erb’s Palsy. In these 
injuries, typically, the patient has a “waiter’s tip” positioning of the arm due to loss of function 
of the deltoid, infraspinatous, and biceps muscles. Less common are lower plexus injuries, 
called Klumpke’s palsy, which most often involves the lower trunk (C8, T1, and sometimes C7). 
Lower plexus injuries result in isolated hand muscle dysfunction.  If the injury or damage is 
proximal to the separation of the sympathetic fibers, the neurological findings include a Horner 
Syndrome, which is characterized by ptosis, miosis, anhidrosis, and pseudoenophthalmos.10  
Obstetrical Brachial Plexus Injuries (OBPI) refers to a brachial plexus injury during delivery. The 
incidence of OBPI ranges globally from 0.2- 4% of live births. Factors that are associated with 
OBPI include large birth weight (>4000 g), prolonged labor course, breech delivery, and 
shoulder dystocia.10 Shoulder dystocia is associated with a 100-fold increased risk of brachial 
plexus injury, which is noted in 11% of shoulder dystocia cases.10 Mothers with diabetes, 
obesity, or preeclampsia, as well as mothers who are multiparous and previously had large 
babies are at higher risk for their children to have OBPI.10 The mechanism for OBPI is thought to 
be a result of an increase in the angle from the infant’s neck to shoulder during birth, creating 
2 
 
traction stretch injury of the brachial plexus. Shoulder dystocia increases the angle of deviation 
of the fetal head during delivery and may cause an increased traction injury on the brachial 
plexus.10 However, some OBPI can occur in utero from increased intrauterine pressure, 
compression of the fetal shoulder on the symphysis pubis, intrauterine maladaptation, failure 
of the shoulders to rotate, and impaction of the posterior shoulder behind the sacral 
promontory.10 Other mechanisms of brachial plexus injury include traumatic injuries causing 
downward or upward traction on the shoulder, penetrating traumatic injury, nerve 
compression, ischemia, neoplastic, radiation induced, thoracic outlet syndrome, hereditary 
brachial plexopathy, and neuralgic amyotrophy.2 
Sufficient injury to the nerves of the BP can result in a wide range of injury severity from mild 
injury to complete nerve root avulsion depending on the extent of stretch, force, and over time. 
Favorable prognosis is associated with early clinical improvement, elbow flexion at 3 to 6 
months of age, normal or near-normal strength in multiple muscle groups.21 Generally, 
prognosis is good and spontaneous complete recovery rates have been reported in up to 95% 
of patients.13 Poor prognostic indicators include Horner Syndrome, no neurologic recovery by 4 
months, and flail upper limb.21  
Physical therapy is the mainstay of treatment to retain passive range of motion, improve 
strengthening, and increase function.  For those patients that do not recover adequate 
function, treatment is primarily surgical in nature. It is recommended that those patients with 
poor prognostic indicators proceed with surgical management. Absence of elbow flexion by 
three to four months of age has historically been used as a predictor of patient benefit from 
surgical management.21  
Surgical treatment is recommended for these patients when they have not recovered function 
by four months. Surgery usually consists of Neurolysis and potential nerve grafting.21 Classically, 
sural nerve graft is harvested from the lower extremity(ies) of the patient to provide sufficient 
material for grafting.  This requires a separate incision(s) as well as morbidity (numbness in the 
sural nerve distribution, dorsum of the foot.)  Acellular deproteinized sural nerve allografts 
provide the matrix for axonal outgrowth without the necessity to sacrifice a function.  Similarly, 
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without need for harvest of the nerve, there is the potential for decreased operative time, 
anesthesia, and complications, leading to better overall outcomes. What is unclear is the 
efficacy in children and in children with OBPI. 
The aim of this study is to determine if using nerve allografts (Axogen) will have similar 
functional outcomes as compared to sural nerve autografts in reconstruction of the brachial 
plexus after OBPI. We hypothesize that sural nerve autografts and Axogen allografts will have 
similar outcomes in motor strength and functional outcome following surgery. We further 
hypothesize that utilizing allograft will have the same rate of complications, rate of future 
surgeries but shorter operative time. 
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Methods 
Approval 
This study was approved by the Phoenix Children's Hospital Institutional Review Board  
(#15-002) as an expedited review. 
Population 
A retrospective chart review included patients who underwent brachial plexus repair after OBPI 
with either an autograft or an Axogen allograft at Barrow Neurological Institute at Phoenix 
Children’s Hospital between 2008-2015 at Phoenix Children’s Hospital by a single surgeon 
(PDA). Patients before August 2012 were given an autograft and after were given an allograft. 
Patients were included in the study if they experienced a lack of functional recovery (Mallet 3 
on hand to mouth testing) of the ipsilateral brachial plexus by 4 months post injury and then 
underwent surgical repair of at Phoenix Children’s Hospital.  Patients who suffered mechanisms 
of Injury other than OBPI or other peripheral nerve injuries were excluded.  
Surgical Approach 
If an autograft is being used, the first step in surgical management is to harvest a nerve graft, 
most commonly a sural nerve. Incision is carried out at the posterolateral aspect of the 
malleolus and identified followed by extending the incision or through cross hatch or stair step 
incisions were performed to provide sufficient length.  Sometimes, this is done bilateral. 
Harvest of the sural nerve creates a permanent insensate patch on the lateral foot that most 
patients do not notice. 
The brachial plexus exploration, neurophysiologic testing, neuroplasty, and nerve grafting were 
the same for autografts and allografts. The supraclavicular approach to the brachial plexus 
begins posterior to the sternocleidomastoid muscle with a linear incision parallel to the clavicle 
approximately 1 finger breadth superior in the posterior triangle. Undermining of the 
surrounding tissues allows for adequate mobilization and flexibility of the approach. The 
platysma is taken down from clavicle and then parallel to the sternocleidomastoid muscle in an 
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“L” shape and the muscle and underlying fat pad are reflected posterosuperiorly. Dissection is 
then deepened to identify each root of the brachial plexus. To determine the extent and 
location of the injury (pre or post ganglionic), electrophysiological studies including 
somatosensory evoked potentials (SSEP) and electromyography (EMG)/ nerve conduction 
studies are performed intraoperatively to determine the function of the neuromuscular unit 
and connection to the spinal cord. If there is no conduction proximally indicating an avulsion, 
then grafting from that nerve root is avoided.  If there is no conduction distally, then the area is 
resected, and an end-to-end “cable” inter-positional nerve graft is fashioned. However, if there 
is conduction across the damaged segment, a neurolysis is first performed and an end-to-side 
“jump” graft is performed, bypassing the neuroma but allowing for new connectivity to form.15 
The autografts are variable in size and condition depending on each individual patient’s 
anatomy.  Allograft consistency was notable for diameter 1-2 mm and using 2- 2.5 cm lengths. 
Primary Outcomes 
Following surgery, the patients undergo physical and or occupational therapy (OT) at least once 
a week with instructions and family teaching to perform range of motion and a full battery of 
exercises multiple times per day.  The children are then followed routinely in our brachial 
plexus clinic every three to six months postoperatively throughout the next two years.  They 
undergo a full neurologic exam and OT assessment at each visit by the senior author/ primary 
surgeon (PDA) and an occupational therapist.  
For this study, the primary outcome measure was the British Medical Research Council (BMRC) 
motor strength scale (converted pediatric motor scale) and functional strength (Mallet score) in 
the pre-operative and post-operative follow up visits.  BMRC Motor Strength Scale utilizes a  
0 - 5 scale where 0 is no muscle contraction and 5 is normal/full contraction (Figure 1). 
Typically, this scale is used in specific ranges of motions to elicit a numeric score for each 
muscle or muscle group.14 This scale has substantial inter- and intra-rater reliability for the 
upper extremity.16 
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Figure 1: British Medical Research Council (BMRC) Motor Strength Scale 
Score Definition 
0 No contraction 
1 Flicker/trace contraction 
2 Active movement with gravity eliminated 
3 Active movement against gravity 
4- Slight movement against resistance 
4 Moderate movement against resistance 
4+ Strong movement against resistance 
5 Normal/full power 
 
Figure 1: BMRC Motor Strength Scale utilizes a 0- 5 scale where 0 is  
no muscle contraction and 5 is normal/full contraction.3 
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For functionality, the Mallet Score is a reliable method for assessing upper extremity function 
utilizing a 1 - 5 score where 1 is no function and 5 is normal function (Figure 2). Seven specific 
functions are tested including lifting the hand to the neck (elevation and external rotation), 
hand to the mouth, placing the hand on the spine (internal rotation), global supination, global 
external rotation, global abduction, and the position of the arm at rest. The Mallet score has 
been shown to be reliable across pediatric age groups.5,21   
The Toronto Score was also recorded for each patient, which is a way to classify functional 
status. The score is 0 - 2, where a 0 is no function, a 1 is decreased function, and a 2 is normal 
function that is symmetrical to the unaffected side. Specific movements that are measured are 
elbow flexion, elbow extension, wrist extension, digit extension, and thumb extension. These 
five movements rated from 0 - 2 are added together to get a score with a maximum of 10.21 
The process of nerve regeneration takes months4; therefore, these assessments would not 
show recovery of function until months after surgery. The endpoint for each patient was last 
clinic visit up to August 2017. 
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Figure 2: Mallet Score 
 
Figure 2: Representation of the modified Mallet Classification for assessing upper trunk 
function. Grade I is no movement. Grade V is normal function, which is symmetric to the 
unaffected side. Grades II, III, and IV are depicted. Scores 1-5 are assigned and correspond to 
the grade.5,14  
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Secondary Outcome Measures 
Secondary outcome measures comparing the autograft and allograft groups included surgical 
length of time, rate of complications, and rate of future need of other surgeries.  We 
hypothesized that surgical time would be decreased with allograft use because it does not 
require separate incisions for nerve graft harvesting as part of surgical management. Increased 
surgical time correlates with increased anesthesia, increased blood loss, increased length of 
stay and consequently increased costs incurred for the patient and the hospital.6,7  As with any 
surgery, complications may arise during or after surgical repair of the brachial plexus. Common 
complications that we followed were infection, neuroma, and painful scar at the repair sites.  
Some patients require additional surgeries to improve function. Typical surgeries after a 
brachial plexus nerve reconstruction that we followed are tendon transfers, muscle transfers, 
tendon releases, muscle releases, humeral osteotomies, and musculotendinous lengthening.  
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Data Collection 
Independent variables that were collected to determine if there were any confounding factors 
included gender, side of injury, birth history, comorbidities, associated injuries, and type of 
surgical repair.  Since all the patients were evaluated and surgically managed by the primary 
surgeon (PDA), the data came from a single rater. However, one study found intra-rater 
reliability to be substantial to excellent in the context of medical records12, which we expect to 
be consistent with our medical record data. 
Power and Sample 
The primary outcome of this power and sample size calculation is the mean difference in the 
change in motor strength and the functional Mallet score from pre-surgery to post-op.  Our 
sample size estimate was 50 patients of approximately equal number in the control group 
(autograft) and in the intervention group (allograft). A clinically significant difference of 0.8 
between the two groups would render a statistical power of 80% with an alpha of 0.05.  Since 
our hypothesis states no statistically significant differences in our outcomes (null hypothesis), 
we expected the score differences to be less than 0.8 between the two groups.  
Statistical Analysis 
Demographic and clinical characteristics of patients who underwent the autograft and allograft 
interventions were evaluated using descriptive statistics including means and standard 
deviations (SD) for continuous variables, frequencies and proportions for categorical variables. 
The Wilcoxon Rank Sum was used to assess the difference in mean scores between patients 
who underwent the autograft and allograft interventions.  The Fisher’s exact test was used to 
compare proportions between the same groups.  The means and standard deviations of our 
outcomes were measured at baseline and post-surgery. The Wilcoxon Signed Rank was used to 
compare differences between pre-surgery and follow up. Multiple linear regression was used to 
ascertain the estimated mean difference of the length of surgery between the two types of 
surgeries utilizing allograft and autograft with the autograft group as the reference group.  
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Multiple logistic regression was used to ascertain the likelihood of subsequent surgeries 
between the allograft and autograft groups using the autograft group as a reference group. To 
compare the complication rate between groups, Fisher’s exact test was used. All p values were 
two sided and p less than 0.05 was considered statistically significant. All data analyses were 
conducted using STATA Version 14 (College Station, Texas).  
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Results 
In total, we identified 52 patients, 22 (42.3%) in the autograft group and 30 (57.7%) in the 
allograft group. The only significant difference in demographics between groups was that the 
autograft group had a greater prevalence of patients with multiparous mothers (64% vs 33%). 
Otherwise, there were no statistically significant differences in demographic and clinical 
characteristics between the groups (Table 1).  With respect to injury type, a noticeable 
difference in the prevalence of right limb injuries was observed between the two groups. Right 
limb injuries were present in 72% of autograft patients and 47% of the allograft patients. 
However, this difference only showed trends toward significance (p=0.06) (Table 2).  Otherwise 
there were no differences between the two groups as to age at surgery, gender or any other 
demographic or clinical characteristic. Of note, the mean time from surgery through last follow-
up was 614 days (+ 547).  
The pre-operative motor assessments compared to the post-operative motor assessments for 
the combined groups (autograft and allograft), showed statistically significant improvements 
for specific muscle groups (Table 3).  The BRMC Motor Strength Score was statistically 
significant for each muscle group we measured except for elbow extension. With regards to 
functionality, each component of the Mallet Score showed statistically significant increases. The 
largest increases within the Mallet Score components were the mean global abduction scores 
(pre-score: 2.23 (0.89) vs post-scores: 3.46 (1.05); p<0.001) and the hand to mouth scores (pre-
score: 1.88 (0.71) vs post-scores: 3.09 (1.06); p<0.001). In terms of the Toronto Score, the 
majority of patients did not have thumb extension recorded in the medical record. Therefore, 
we were unable to calculate the difference in thumb extension or use the complete score. 
Similar to the BRMC and Mallet score, the Toronto Score showed statistically significant 
improvements for the combined groups in every range of motion except for elbow extension. 
This is evidence that overall, patients improved from the surgical procedure pre-operative to 
post-operative and gained functionality.   
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Table 1: Demographics and Clinical Characteristics 
Variables Autograft N=22 
Allograft 
N=30 P-value 
Gender (male, %) 
 
Maternal Medical History 
8 (36.4) 17 (56.7) 0.15 
Maternal Musculoskeletal Disorders (yes, %) 0 (0.0) 1 (3.3) 1.0 
Maternal Gestational Diabetes (yes, %) 4 (18.2) 1 (3.3) 0.15 
Maternal Hypertension (yes, %) 5 (22.7) 3 (10.0) 0.26  
Maternal Immune-compromised (yes, %) 0 (0.0) 0 (0.0) N/A 
Maternal Difficult Healing (yes, %) 0 (0.0) 1 (3.33) 1.0  
Maternal Peripheral Neuropathy (yes, %) 0 (0.0) 0 (0.0) N/A 
Maternal Excessive Weight Gain in Pregnancy  
(yes, %) 1 (4.55) 0 (0.0) 0.42 
Other Maternal history (yes, %) 12 (54.6) 18 (60.0) 0.69 
Mother’s Occupation (Office Admin, %) 7 (31.8) 13 (43.3) 0.24 
Smoking History (Non-Smoker, %) 14 (63.6) 19 (63.3) 0.98 
Mother’s Pregnancy Number (Gravida, n, %) 
1 
2 
>3 
 
8 (36.4) 
2 (9.09) 
12 (54.6) 
 
12 (40.0) 
8 (26.7) 
10 (33.3) 
0.20 
Number of Live Children Delivered (>1, %) 14 (63.6) 10 (33.3) 0.03 
 
Child’s Medical History 
Delivery (Cesarean-Section, %) 
 
 
3 (13.6) 
 
 
1 (3.57) 
 
 
0.30 
Shoulder Dystocia (yes, %) 17 (77.3) 17 (56.7) 0.15 
Vacuum (yes, %) 4 (18.2) 4 (13.3) 0.70 
Forceps (yes, %) 3 (13.6) 4 (13.3) 1.0 
Need for Neonatal Intensive Care (yes, %) 4 (18.2) 2 (6.67) 0.38 
Sibling with OBPI (yes, %) 0 (0.0) 0 (0.0) N/A 
Neurological Disorder (yes, %) 2 (9.09) 1 (3.33) 0.56 
Peripheral Neuropathy (yes, %) 0 (0.0) 0 (0.0) N/A 
Musculoskeletal Disorder (yes, %) 0 (0.0) 2 (6.67) 0.50 
Diabetes (yes, %) 0 (0.0) 0 (0.0) N/A 
Hypertension (yes, %) 0 (0.0) 0 (0.0) N/A 
Immuno-compromised (yes, %) 0 (0.0) 0 (0.0) N/A 
Difficulty Healing (yes, %) 0 (0.0) 0 (0.0) N/A 
    
Chi-Squared/Fisher’s Exact to compare categorical variables.   
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Table 2: Characteristics of Nerve Injury 
Variables Autograft N=22 
Allograft 
N=30 P-value 
Mechanism of injury (OBPI, %) 21 (95.5) 29 (96.7) 1.0 
Affected Limb (right, %) 16 (72.7) 14 (46.7) 0.06 
C5 (post-ganglionic, %) 19 (86.4) 23 (76.7) 0.48 
C6 (post-ganglionic, %) 19 (86.4) 24 (80.0) 0.71 
C7 (post-ganglionic, %) 15 (68.2) 21 (70.0) 0.88 
C8 (post-ganglionic, %) 3 (13.6) 4 (13.3) 1.0 
T1 (post-ganglionic, %) 2 (9.09) 3 (10.0) 1.0 
Fracture to Clavicle (yes, %) 0 (0.0) 3 (10.0) 0.25 
Fracture to Humerus (yes, %) 0 (0.0) 1 (3.33) 1.0 
Phrenic Nerve Injury (yes, %) 0 (0.0) 0 (0.0) N/A 
Anoxic Brain Injury (yes, %) 0 (0.0) 1 (3.33) 1.0 
Horner’s Syndrome (yes, %) 2 (9.09) 2 (6.67) 1.0 
    
Chi-Squared/Fisher’s Exact to compare categorical variables. 
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Table 3: Mean Pre- and Post-Operative for Groups Combined 
Variables Pre Mean, SD Post Mean, SD P-value 
BMRC Motor Score     
Shoulder Flexion AMS 2.07 (1.24) 3.36 (1.09) <0.001 
Shoulder Abduction AMS 2.80 (3.49) 3.61 (1.16) <0.001 
Shoulder External Rotation AMS 0.77 (0.92) 2.48 (1.50) <0.001 
Elbow Flexion AMS 2.22 (1.29) 3.61 (1.12) <0.001 
Elbow Extension AMS 3.45 (1.35) 3.70 (1.26) 0.23 
Forearm Pronation AMS 3.37 (1.23) 4.09 (0.81) <0.001 
Forearm Supination AMS 1.22 (1.09) 2.57 (1.44) <0.001 
Wrist Flexion AMS 3.26 (1.63) 4.08 (1.31) <0.001 
Wrist Extension AMS 2.78 (1.70) 3.67 (1.51) <0.001 
Digit Flexion AMS 3.67 (1.58) 4.15 (1.00) 0.005 
Digit Extension AMS 3.27 (1.55) 4.00 (1.19) <0.001 
 
Mallet Score 
Arm at Rest 
 
 
2.20 (0.90) 
 
 
3.02 (0.98) 
 
 
<0.001 
Global Abduction 2.23 (0.89) 3.46 (1.05) <0.001 
Global External Rotation 2.11 (0.79) 3.00 (0.84) <0.001 
Head and Neck 1.81 (0.62) 2.81 (1.29) <0.001 
Head and Spine 1.93 (0.66) 2.90 (0.89) <0.001 
Head to Mouth 1.88 (0.71) 3.09 (1.06) <0.001 
Supination 1.93 (0.75) 2.92 (0.84) <0.001 
 
Toronto Score 
Elbow Flexion 
 
 
0.86 (0.34) 
 
 
1.11 (0.32) 
 
 
0.001 
Elbow Extension 1.00 (0.30) 1.07 (0.34) 0.31 
Wrist Extension 0.86 (0.48) 1.32 (0.53) 0.011 
Digit Extension 1.03 (0.47) 1.28 (0.45) 0.018 
 
Scapular Elevation 
 
2.38 (0.77) 
 
2.20 (0.76) 
 
0.53 
    
Wilcoxon Signed Rank to compare Pre- to Post-Op. 
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When the study groups were separated, they each showed an improvement in scores (Table 4).  
In fact, every component we measured had an average improvement, as shown by the positive 
numbers in Table 4, except for elbow extension and scapular elevation in the autograft group. 
However, the change in scores showed no statistically significant difference between the 
autograft and allograft groups (p>0.05).  Ultimately, the autograft and allograft groups had 
similar increases in scores, meaning that neither one was superior in this study, a finding 
consistent with our initial hypothesis. 
The length of surgery time showed that there was a decrease of 30.7 minutes (Coef (95% CI): -
30.7 (.62.7, 1.31): p=0.06) in the allograft group as compared to autograft.  There were 
secondary predictors that showed trends towards significance with regards to decreasing 
surgical times (Maternal Diabetes (p=0.07) and multiparous mothers p=0.08). The primary 
covariate that was associated with a statistically significant increase in surgery length was if the 
patient had a comorbid neurological disorder, which was associated with an increase of surgical 
length of 82.3 minutes (Coef (95% CI): 82.3 (6.82, 157.8); p=0.03) (Table 5).   
The rate of subsequent surgeries was not statistically different between groups. In the allograft 
group, patients were 2.69 times more likely to have a subsequent surgery (such as a tendon or 
muscle release or transfer), however this was not statistically significant and had a large 
confidence interval (OR (95% CI) = 2.69 (0.30, 23.9); p = 0.37) (Table 6).  There were no 
complications reported for the allograft group. There were two patients that had superficial 
infections with stitch abscesses in the autograft group in the incisions for the sural nerve 
harvest. There were no infections in the primary supraclavicular surgical site in either group. 
The complication rate was therefore not significantly different for autografts 9% and for 
allografts 0% (p=0.17). 
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Table 4: Change in Mean between Groups 
Variables Autograft N=22 
Allograft 
N=30 P-value 
 Δ Mean, SD Δ Mean, SD  
BMRC Motor Score    
Shoulder Flexion AMS 1.17 (0.41) 1.46 (1.12) 0.83 
Shoulder Abduction AMS 1.42 (0.79) 0.58 (4.52) 0.97 
Shoulder External Rotation AMS 1.87 (1.35) 2.11 (1.49) 0.64 
Elbow Flexion AMS 1.43 (1.34) 1.40 (1.24) 0.51 
Elbow Extension AMS -0.14 (1.23) 0.41 (1.08) 0.22 
Forearm Pronation AMS 0.50 (0.55) 0.95 (1.19) 0.55 
Forearm Supination AMS 1.45 (1.21) 1.40 (1.31) 0.89 
Wrist Flexion AMS 1.13 (1.64) 0.73 (1.16) 0.49 
Wrist Extension AMS 0.13 (1.72) 1.19 (1.46) 0.35 
Digit Flexion AMS 0.23 (1.01) 0.67 (1.20) 0.50 
Digit Extension AMS 0.40 (0.69) 1.04 (1.25) 0.17 
 
Mallet Score 
Arm at Rest 
 
 
0.71 (0.72) 
 
 
0.78 (0.95) 
 
 
0.79 
Global Abduction 1.07 (1.11) 1.25 (0.75) 0.66 
Global External Rotation 1.00 (0.78) 0.78 (0.75) 0.37 
Head and Neck 1.07 (1.03) 0.93 (1.29) 0.56 
Head and Spine 1.00 (0.84) 1.00 (0.87) 0.94 
Head to Mouth 1.31 (0.94) 1.11 (1.18) 0.54 
Supination 0.71 (0.82) 1.11 (0.99) 0.23 
 
Toronto Score 
Elbow Flexion 
 
 
0.21 (0.42) 
 
 
0.25 (0.45) 
 
 
0.75 
Elbow Extension 0.14 (0.53) 0.04 (0.44) 0.49 
Wrist Extension 0.17 (0.93) 0.41 (0.50) 0.63 
Digit Extension 0.17 (0.71) 0.34 (0.64) 0.46 
 
Scapular Elevation 
 
-0.71 (1.49) 
 
0 (0.89) 
 
0.14 
    
Wilcoxon Rank Sum to compare continuous variables.   
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Figure 3: Change in Mean from Pre- to Post-Op 
 
Figure 3: Graph showing Table 4 in pictorial format. The change in mean from pre- to post-op in 
the autograft and allograft groups is not statistically significant. 
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Table 5: Association between Group and Length of Surgery 
Variables Beta (95% CI) P-value 
Graft 
Autograft 
Allograft 
 
REF 
-30.7 (-62.7, 1.31) 
 
 
0.06 
Gender 
Female 
Male 
 
REF 
-1.85 (-35.2, 31.5) 
 
 
0.91 
Maternal Musculoskeletal Disorder 
No 
Yes 
 
REF 
76.84 (-18.0, 171.7) 
 
 
0.11 
Maternal Diabetes 
No 
Yes 
 
REF 
-57.7 (-122.5, 7.14) 
 
 
0.07 
Maternal Hypertension 
No 
Yes 
 
REF 
-24.1 (-66.6, 18.5) 
 
 
0.25 
Number of Children 
< 1 
>1 
 
REF 
-27.1 (-60.4, 4.44) 
 
 
0.08 
Delivery 
Vaginal 
C-Section 
 
REF 
-2.34 (-56.6, 51.9) 
 
 
0.93 
NICU Stay 
No 
Yes 
 
REF 
11.6 (-37.9, 61.1) 
 
 
0.63 
Patient Neurological Disorder 
No 
Yes 
 
REF 
82.3 (6.82, 157.8) 
 
 
0.03 
Affected Limb 
Left 
Right 
 
REF 
-1.47 (-29.8, 26.8) 
 
 
0.81 
C5 Injury 
No 
Yes 
 
REF 
-13.8 (-57.8, 30.2) 
 
 
0.52 
C6 Injury 
No 
Yes 
 
REF 
-23.0 (-68.9, 22.9) 
 
 
0.31 
Clavicle Fracture 
No 
Yes 
 
REF 
49.1 (-8.10, 106.2) 
 
 
0.09 
   
Beta (95% CI) calculated using Multiple Linear Regression  
adjusting for all other variables in the model. 
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Table 6: Association between Graft and Subsequent Surgery 
Variables OR (95% CI) P-value 
Graft 
Autograft 
Allograft 
 
REF 
2.69 (0.30, 23.9) 
 
 
0.37 
Gender 
Female 
Male 
 
REF 
0.27 (0.04, 2.01) 
 
 
0.21 
Maternal Diabetes 
No 
Yes 
 
REF 
0.11 (0.002, 6.01) 
 
 
0.28 
Occupation 
Other  
Office Assistant 
 
REF 
4.16 (1.10, 15.6) 
 
 
0.04 
Number of Children 
< 1 
>1 
 
REF 
0.19 (0.02, 2.05) 
 
 
0.17 
Delivery 
Vaginal 
C-Section 
 
REF 
0.20 (0.0001, 246.7) 
 
 
0.66 
NICU Stay 
No 
Yes 
 
REF 
13.8 (0.53, 359.1) 
 
 
0.11 
Affected Limb 
Left 
Right 
 
REF 
4.92 (0.79, 31.4) 
 
 
0.08 
C5 Injury 
No 
Yes 
 
REF 
0.07 (0.006, 0.93) 
 
 
0.04 
Clavicle Fracture 
No 
Yes 
 
REF 
12.0 (0.56, 256.7) 
 
 
0.11 
OR (95% CI) calculated using Multiple Logistic Regression  
adjusting for all other variables in the model. 
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Discussion 
Our study has found that the utilization of autograft and allograft for the treatment of OBPI 
during the primary surgery to repair the brachial plexus were found to be equally efficacious 
with regards to functional outcomes as measured by the BRMC Motor Strength Score, Mallet 
score, and Toronto Score.  Importantly, all of the children who underwent surgical intervention 
utilizing these grafting materials were found to improve and most were able to gain 
functionality (i.e.) ability to get their hand to mouth to feed themselves.  The surgical time was 
shorter in the utilization of allograft although this only showed a trend toward significance. Our 
analysis showed no difference in the rate of subsequent surgeries or complications. 
Nerve grafting 
Peripheral nerve allograft safety and functionality in animal models has been well established.1 
However, there is still controversy about the efficacy of allografts in comparison to autografts in 
animal models. In one study there was a significant decrease in nerve fibers and muscle mass in 
the acellular nerve allograft group.22 In another study, there was no difference between 
autograft and allograft groups in terms of electrophysiologic or histomorphologic outcomes.20 
In yet another study, acellular nerve allografts were superior to cabled nerve autografts in 
normalized maximum isometric tetanic force.19 
However, not many studies have attempted to determine the efficacy of decellularized 
cadaveric nerve allografts for return of strength and functionality in humans, especially in 
comparison to autografts in a pediatric population. Reports and case series show mixed efficacy 
of allografts and there is no current consensus on the optimal use of autografts as compared to 
allografts though for generally long segments (> 5 cm), autografts may be better.11,18 Our study 
compared autografts to decellularized cadaveric nerve allografts in children with multiple 
outcome measures that have not previously been compared. In our study, allograft efficacy 
may be tied to the short segment and methodology for their utilization though this would need 
further study to better understand the electrophysiologic and histomorphologic outcomes in 
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this patient population. The graft segments tended to be short (< 2.5 cm) and may have 
contributed to the equal efficacy between the groups.   
Allograft (Avance®) Nerve Grafts are processed cadaveric human nerves that are sterilized, 
decellularized, and deproteinized. The structure of the extracellular matrix of the nerve is 
retained and provides a three-dimensional scaffold for axon regeneration across a peripheral 
nerve discontinuation.4 Histologic examinations have concluded that decellularized nerve 
allografts have a suitable scaffold for bridging nerve discontinuities.20 A large benefit of using 
Axogen allografts is the lack of co-morbidities associated with harvesting an autograft, most 
commonly the sural nerve. The allografts are flexible enough to be used across joints and come 
in diameters up to 5mm and lengths up to 70 mm.4  In this study 1-2 mm diameter grafts were 
used with generally < 2.5 cm lengths to perform the jump grafts. 
Allografts help the peripheral nerve to repair itself using the extracellular matrix scaffold to aid 
in axon regeneration. The first step in the process of repair is for the matrix to be vascularized, 
which happens within hours of the surgical repair. In a few days post operatively, Schwann cells 
migrate into the matrix and form tube-like structures that subsequently guide the axon 
regeneration. Within weeks, many of these tubes formed by Schwann cells have regenerating 
axons within them. Within months, these regenerating axons grow the full length of the 
allograft and with axon maturation, become thicker and myelinated.4 
Safety of acellular nerve allografts in humans has been well established.8,9,18,23 In humans, 
limited studies have been done to determine efficacy differences between autografts and 
allografts. In an adult population, it has been shown that autografts and allograft sensory 
outcomes were similar in digital nerve reconstruction.17 When comparing historical autograft 
data to peripheral nerve reconstruction using processed nerve allografts in an adult population, 
studies suggest that efficacy is similar.8,9 Through an extensive literature search, we have not 
found any studies that compared allografts to autografts in a pediatric population. Our study 
would seem to indicate that use of the allografts is safe and with potentially less complications 
than the use of autografts.  
23 
 
Limitations 
The largest limitation of this study is the small sample size. The multiple inclusion criteria for 
this project limited the sample size to one mechanism of injury in one hospital. The Mallet score 
is on a scale of 0 to 5 and the change in mean score was relatively small, between 0.71 to 1.31 
for the autograft group and 0.75 to 1.25 for the allograft group. The standard deviations were 
large in comparison to the change in mean, as seen in Table 4. This study was powered to 
detect a difference of score of 0.8, to be able to detect a significant difference pre-operative to 
post-operative motor and functional outcome but was not able to detect any small possible 
difference between groups.  
Other limitations were non-randomized patient population, possibly allowing for unknown 
factors between the two groups. As the data was collected from the electronic medical record, 
the medical staff was not blinded to the surgery the patient received. 
One possible future direction would be a cost analysis. In order to quantify the amount that 
could be saved, a cost analysis could be done to consider the cost of the operative time saved 
with using allografts vs. the cost of the allografts themselves. This could provide not only a 
clinical rational to use allografts but a cost savings rationale as well. Cost but also cost 
effectiveness is always a consideration in this ever expanding and unsustainable healthcare 
environment. 
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Conclusions 
Our analysis showed that autografts and allografts are equally efficacious in the treatment of 
the primary injury in children with OBPI. With two equally efficacious methods, the less invasive 
method would seem to be preferable. We suggest that this is the case with allografts.  
Allograft use only requires one surgical site and inherently has a lack of comorbidities 
associated with a second surgical site. In our population, although not statistically significant, 
there were fewer infections in the allograft group. In the autograft group, there were two 
infections due to the incisions in the leg from the nerve harvest. 
In addition, the use of allografts has the potential for better repair for extensive lesions. Nerve 
autografts can only provide a certain length of graft, whereas the amount of allograft is not 
limited to what can be harvested. For patients with large discontinuities or multiple levels of 
the brachial plexus, allografts have the potential to provide repair for all nerves involved 
instead of just a few. 
Allograft surgery length was shorter in our cohort. Decreased surgical time implies decreased 
time under anesthesia and decreased risks associated with anesthesia. Considering many of 
these surgeries are multiple hours long in young children, decreased anesthetic exposure would 
be favored as long-term effects of exposure to anesthesia in pediatric patients is unknown. It 
also has the potential to decrease the complications associated with prolonged anesthetic 
usage.  
For these reasons, nerve allografts are the preferable route for surgical management. 
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